These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16038107)
1. Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies. von Scheven E; Elder ME Lupus; 2005; 14(6):440-4. PubMed ID: 16038107 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome. Gushiken FC; Arnett FC; Ahn C; Thiagarajan P Arthritis Rheum; 1999 Jun; 42(6):1189-93. PubMed ID: 10366111 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies. Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173 [TBL] [Abstract][Full Text] [Related]
4. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. von Scheven E; Glidden DV; Elder ME Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid syndrome: 30 years and our contribution. Koike T Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556 [TBL] [Abstract][Full Text] [Related]
6. Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome. Atsumi T; Tsutsumi A; Amengual O; Khamashta MA; Hughes GR; Miyoshi Y; Ichikawa K; Koike T Rheumatology (Oxford); 1999 Aug; 38(8):721-3. PubMed ID: 10501418 [TBL] [Abstract][Full Text] [Related]
7. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease. Rauch J; Salem D; Subang R; Kuwana M; Levine JS Front Immunol; 2018; 9():2836. PubMed ID: 30619248 [TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
10. Val/Leu247 polymorphism of β2-glycoprotein I and thrombosis in Chinese patients with SLE. Liang W; Zhou J; Zhou S; Wang T; Yang L; Xu D; Deng G; Huang D; Mei C; He Y; Zhang Z Int J Lab Hematol; 2015 Feb; 37(1):22-8. PubMed ID: 24661363 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478 [TBL] [Abstract][Full Text] [Related]
12. The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus. Salem D; Subang R; Laplante P; Levine JS; Rauch J Lupus; 2014 Oct; 23(12):1327-31. PubMed ID: 25228740 [TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
14. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
15. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies. Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
17. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients. Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301 [TBL] [Abstract][Full Text] [Related]
18. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus. Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423 [TBL] [Abstract][Full Text] [Related]
19. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [TBL] [Abstract][Full Text] [Related]